Lancashire and South Cumbria
Formulary
Formulary
7 Obstetrics, Gynaecology, and urinary-tract disorders
07-03-02-01 Oral progestogen-only contraceptives
| Desogestrel |
|
Formulary
|
| Tablets 75 micrograms |
 MHRA: St John’s wort: interaction with hormonal contraceptives, including implants |
|
| Levonorgestrel |
|
Formulary
|
Tablets 30 micrograms |
|
MHRA: St John’s wort: interaction with hormonal contraceptives, including implants |
|
|
| Norethisterone |
|
Formulary
|
Tablets 350 micrograms Menstrual disorders. |
|
MHRA: St John’s wort: interaction with hormonal contraceptives, including implants |
|
|
Links
- FSRH Clinical Guideline: Contraceptive Choices for Young People
- FSRH Statement: Glucagon-like peptide-1 (GLP-1) agonists and oral contraception
- FSRH: Progestogen-only Pills
- FSRH: Standards & Guidance
- FSRH: UK Medical Eligibility Criteria for Contraceptive Use (UKMEC)
LSCMMG: Erectile Dysfunction Guideline- LSCMMG: Overactive bladder in female adults
- MHRA: Medicines with teratogenic potential: what is effective contraception and how often is pregnancy testing needed?
- MHRA: St John’s wort: interaction with hormonal contraceptives, including implants
- MHRA: St John’s wort: interaction with hormonal contraceptives, including implants
- MHRA: St John’s wort: interaction with hormonal contraceptives, including implants
- MHRA: St John’s wort: interaction with hormonal contraceptives, including implants
- NICE CG30: Long-acting reversible contraception
- NICE CG97: Lower urinary tract symptoms in men: management
- NICE NG123: Urinary incontinence and pelvic organ prolapse in women: management
- NICE NG133: Hypertension in pregnancy: diagnosis and management
- NICE NG194: Postnatal care
- NICE NG210: Pelvic floor dysfunction: prevention and non-surgical management
- NICE NG3: Diabetes in pregnancy: management from preconception to the postnatal period
- NICE NG88: Heavy menstrual bleeding: assessment and management